Vascular endothelial growth factor (VEGF) is an important mediator of angiogenesis in diabetic retinopathy, cancer and coronary heart disease. The expression of VEGF is tightly controlled to the cellular oxygen tension. Previous studies have shown that VEGF mRNA is markedly stabilized under hypoxic conditions. The molecular mechanisms underlying the regulation of VEGF mRNA stability are not well understood. In the preliminary results the applicant showed that the stability of VEGF mRNA is controlled by a cis acting element in its 3'UTR. They have also identified a trans acting factor (HuR) that binds to this element and increases the expression of VEGF. In addition, they show that HuR itself is regulated by hypoxia. This proposal will focus on the role of HuR in hypoxic regulation of VEGF mRNA stability. The proposed studies may be important since they could lead to the generation of new drugs that will regulate VEGF expression at the post transcriptional level.
The specific aims of the proposal are the following: (1) To determine the fine structure of the HuR/VEGF mRNA complex. To generate mutations in both the mRNA element and HuR and determine their effect on VEGF expression; (2) To design selective inhibitors of HuR/VEGF mRNA complexes; (3) To identify and clone HuR associate proteins that modify its activity; (4) To determine how hypoxia regulates HuR expression; and (5) To determine how HuR stabilizes VEGF mRNA.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Pathology A Study Section (PTHA)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Connecticut
Anatomy/Cell Biology
Schools of Medicine
United States
Zip Code
Roguin, Ariel; Avivi, Aaron; Nitecki, Samy et al. (2003) Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF. Proc Natl Acad Sci U S A 100:4644-8
Sengupta, Sibani; Jang, Byeong-Churl; Wu, Ming-Tao et al. (2003) The RNA-binding protein HuR regulates the expression of cyclooxygenase-2. J Biol Chem 278:25227-33
Goldberg-Cohen, Ilana; Furneauxb, Henry; Levy, Andrew P (2002) A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. J Biol Chem 277:13635-40
Melamed-Frank, M; Terzic, A; Carrasco, A J et al. (2001) Reciprocal regulation of expression of pore-forming KATP channel genes by hypoxia. Mol Cell Biochem 225:145-50
Hochberg, I; Hoffman, A; Levy, A P (2001) Regulation of VEGF in diabetic patients with critical limb ischemia. Ann Vasc Surg 15:388-92
Melamed-Frank, M; Lache, O; Enav, B I et al. (2001) Structure-function analysis of the antioxidant properties of haptoglobin. Blood 98:3693-8
Zhao, Z; Chang, F C; Furneaux, H M (2000) The identification of an endonuclease that cleaves within an HuR binding site in mRNA. Nucleic Acids Res 28:2695-701